Insulin infusion management device and insulin infusion management system

Abstract

The invention relates to an insulin infusion management device and an insulin infusion management system.The insulin infusion management device is characterized in that a user interface comprises a real-time monitoring interface; the information statistics display area of the real-time monitoring interface displays a blood glucose change curve generated according to the blood glucose monitoring information and the first association relationship; when the blood glucose level recording point is input and selected by the first user, the information statistics display area is controlled to display a numerical value display area in a floating mode, and the numerical value display area is perpendicularly connected with the selected blood glucose level recording point through a dotted line indication line so that the numerical value display area and the blood glucose change curve can be completely displayed at the same time in the information statistics display area; and receiving a dragging operation input by a second user, and displaying the corresponding blood glucose monitoring information and / or insulin infusion information in an associated manner according to the blood glucose level recording point. The safety and reliability of insulin infusion control and blood glucose monitoring are ensured, and the user experience is improved.

Description

[0001] This application is a divisional application of the application with the application date of November 4, 2024, application number 202411555774.0, and invention name "Insulin Infusion Management Device, Insulin Infusion Management System and Method". Technical Field

[0002] This application relates to the field of insulin infusion control, and particularly to an insulin infusion management device and an insulin infusion management system. Background Art

[0003] Diabetes is a chronic disease. It occurs when the pancreas cannot produce enough insulin or the body cannot effectively utilize the insulin produced. Insulin is a hormone that regulates blood sugar. High blood sugar, or hyperglycemia, is a common consequence of uncontrolled diabetes and can cause serious damage to many systems of the body (especially the nerves and blood vessels) over time. Therefore, self-monitoring of blood sugar and subcutaneous insulin infusion are typical methods for treating diabetes. An insufficient dose of infused insulin can lead to hyperglycemia, while an excessive dose of insulin can lead to hypoglycemia. Prolonged hypoglycemia can result in mental clumsiness, difficulty speaking, confusion, loss of consciousness, seizures, or death. Therefore, people with diabetes (PWD) face a considerable cognitive burden when determining the appropriate infusion dose.

[0004] Currently, under the premise of following medical advice, people with diabetes use an insulin infusion device and a continuous blood glucose monitoring device to achieve insulin infusion function and blood glucose monitoring respectively. Existing insulin infusion devices and continuous blood glucose monitoring devices cannot provide wireless communication between system components, nor can they simultaneously display the safe operation of insulin infusion control and blood glucose monitoring, and the user experience needs to be improved. Summary of the Invention

[0005] In this embodiment, an insulin infusion management device and an insulin infusion management system are provided.

[0006] In a first aspect, in this embodiment, an insulin infusion management device is provided, including: a communication module and a user interface; wherein: the communication module is used to receive blood glucose monitoring information and insulin infusion information carrying time information;

[0007] The user interface includes a large-dose infusion setting interface and an information statistics display area;

[0008] The large-dose infusion setting interface is used to respond to a third user input to set single large-dose infusion information or multiple large-dose infusion information at the same moment;

[0009] The information statistics display area is used to display a first bar chart, and the first bar chart is used to show the user the changes in large-dose infusion information in the past and current time; wherein, the first bar chart includes a first single-color block and / or a first multi-color combination block, and the single large-dose infusion information is displayed using the first single-color block, and the multiple large-dose infusion information at the same moment is displayed using the first multi-color combination block.

[0010] In some embodiments, the upper column, middle column, and lower column of the first multi-color combination block are distinguished and displayed by different colors or different textures;

[0011] The information statistics display area is further used to correspondingly display a text description of the doses of multiple consecutive infusions above the first multi-color combination block.

[0012] In some embodiments, the user interface further includes a large-dose estimation interface; the large-dose estimation interface includes a blood glucose value setting area; the blood glucose value setting area is used to display a first option and a second option; the first option is used to select the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information; the second option is used to select the current finger-prick blood value as the current blood glucose monitoring information;

[0013] The blood glucose value setting area is further used to, in response to a sixth user input for selecting the first option, take the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information, and set the second option to not respond to user input operations; and, in response to a seventh user input for selecting the second option, take the received current finger-prick blood value as the current blood glucose monitoring information.

[0014] In some embodiments, the user interface further includes a basal rate infusion setting interface, and the basal rate infusion setting interface is used to set regular basal rate infusion information or temporary basal rate infusion information at different times in response to a fourth user input;

[0015] The information statistics display area further displays a second bar chart, and the second bar chart is used to display regular basal rate information or temporary basal rate numerical information at different times; wherein, there is a partially overlapping area between the first bar chart and the second bar chart, and the first bar chart and the second bar chart are distinguished and displayed.

[0016] In some embodiments, the user interface further includes a statistical analysis interface; the statistical analysis interface includes a blood glucose statistics area, a blood glucose overview area, and an injection overview area;

[0017] The blood glucose statistics area is used to respond to the user's selection operation of the statistical date, and statistically display the blood glucose change statistical chart, large dose infusion statistical chart, and basal rate infusion statistical chart corresponding to the statistical date;

[0018] The blood glucose overview area is used to respond to the user's selection operation of the statistical date, and statistically display the multi-dimensional blood glucose status quantification indicators corresponding to the statistical date;

[0019] The injection overview area is used to respond to the user's selection operation of the statistical date, and statistically display the total amount of insulin, total amount of large dose, total amount of basal rate, and total amount of carbohydrates corresponding to the statistical date.

[0020] In some of the embodiments, the user interface further includes a real-time monitoring interface;

[0021] The real-time monitoring interface further includes a control mode display area; the control mode display area is used to indicate that the current control of the insulin infusion device is in manual mode or automatic mode; wherein, when the control mode display area shows manual mode, the infusion control of the insulin infusion device is manually controlled by the user; when the control mode display area shows automatic mode, the infusion control of the insulin infusion device is automatically based on the control of the insulin infusion management device.

[0022] In some of the embodiments, the real-time monitoring interface further includes a first details button;

[0023] The first details button is used to respond to the user's click operation, and pop up a first prompt box on the real-time monitoring interface; wherein: the first prompt box contains the status information of the associated blood glucose monitoring device, the status information of the insulin infusion device, and the first prompt box of the total amount of insulin and average blood glucose within a preset time period; or,

[0024] Pop up the first prompt box above the real-time monitoring interface; the first prompt box contains: the brand name, serial number, connection status, remaining days, activation time, and time since the last calibration of the associated blood glucose monitoring device.

[0025] In some of the embodiments, the real-time monitoring interface further includes an insulin infusion display area and a device information display area;

[0026] The insulin infusion display area is used to display the basal rate infusion information and the large dose infusion information; the large dose infusion information includes the dose value and infusion time of the most recent large dose infusion;

[0027] The device information display area is used to display the remaining usage time of the associated blood glucose monitoring device.

[0028] In some of these embodiments, the real-time monitoring interface is divided into multiple operable area modules; each of the area modules is associated with a listening event;

[0029] In response to a user's custom display operation on any area module, the area module operated by the user is hidden, displayed, or its position layout is modified.

[0030] In a second aspect, an insulin infusion management system is provided in this embodiment, including: a blood glucose monitoring device, an insulin infusion device, and the insulin infusion management device described in the first aspect above; wherein:

[0031] The blood glucose monitoring device is used to monitor blood glucose to obtain blood glucose monitoring information;

[0032] The insulin infusion management device is used to receive and display the blood glucose monitoring information and insulin infusion information, and generate an infusion instruction according to the blood glucose monitoring information and insulin infusion information;

[0033] The insulin infusion device is used to receive the infusion instruction and perform insulin infusion.

[0034] In some of these embodiments, the insulin infusion management device is further used to send a pairing or de - pairing initiation request to the insulin infusion device;

[0035] The insulin infusion device is further used to send a pairing or de - pairing initiation response to the insulin infusion management device in response to the initiation request; wherein, the initiation response contains a binding feature code;

[0036] The insulin infusion device is used to receive a pairing or de - pairing confirmation request sent by the insulin infusion management device during pairing or de - pairing confirmation, and determine whether the binding feature code in the confirmation request is the binding feature code contained in the initiation response; if so, confirm that the pairing or de - pairing operation is successful; otherwise, confirm that the pairing or de - pairing operation fails.

[0037] In this embodiment, an insulin infusion management device and an insulin infusion management system are provided. The insulin infusion management device therein provides a user interface that enables insulin infusion control and blood glucose monitoring for the user. This user interface can simplify the insulin infusion control operation, reduce the user's cognitive burden regarding insulin infusion, and provide the user with a richer operation experience. Additionally, the interactive user interface provided in this embodiment displays the insulin infusion situation, records the large doses set for a single time and the large doses infused multiple times, and clearly, concisely, accurately, and intuitively presents the infusion information in the continuous large-dose infusion scenario, facilitating the user to more clearly and comprehensively manage the large-dose infusion information and enhancing the user experience. In some cases, the insulin infusion device of this embodiment can also prominently display the operable information, thereby reducing the user's operation difficulty and enabling ordinary users to quickly determine the appropriate insulin infusion actions. Furthermore, in some cases, the insulin infusion management device of this embodiment can adapt to insulin infusion under different user activities such as meals, exercise, and taking medications, and correspondingly display the events that affect blood glucose and insulin infusion. This embodiment can also display the monitored blood glucose data on the user interface to achieve real-time monitoring of blood glucose levels. In some cases, the user interface provided in this embodiment can also present the usage status and maintenance information of the associated blood glucose monitoring device and insulin infusion device to notify the user to promptly carry out device maintenance activities and the system problems that need to be maintained detected. Therefore, the insulin infusion management device provided in this embodiment can ensure the safety and reliability of insulin infusion control and blood glucose monitoring from different dimensions such as insulin infusion control, infusion display, and blood glucose monitoring, and enhance the user experience.

[0038] Details of one or more embodiments of this application are set forth in the following drawings and description to make other features, objects, and advantages of this application more concise and understandable. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] The drawings described herein are used to provide a further understanding of this application and form a part of this application. The illustrative embodiments of this application and their descriptions are used to explain this application and do not constitute an improper limitation of this application. In the drawings:

[0040] Figure 1 is a schematic structural diagram of the insulin infusion management device of this embodiment;

[0041] Figure 2 is a schematic interface diagram of the insulin infusion management device of this embodiment;

[0042] Figure 3 is a schematic diagram of the information statistics display area of this embodiment;

[0043] Figure 4Schematic structural diagram of the large-dose estimation interface of this embodiment;

[0044] Figure 5 Schematic structural diagram of the insulin infusion management system of this embodiment;

[0045] Figure 6 Schematic structural diagram of an insulin infusion device of this embodiment;

[0046] Figure 7 Flowchart of the insulin infusion management method of this embodiment. Detailed implementation manners

[0047] To understand the purpose, technical solution and advantages of this application more clearly, the following describes and explains this application with reference to the accompanying drawings and embodiments.

[0048] Unless otherwise defined, the technical terms or scientific terms involved in this application shall have the general meanings understood by those with ordinary skills in the technical field to which this application belongs. In this application, words such as "a", "one", "a kind of", "the", "these" and the like do not indicate a limitation in quantity, and they can be singular or plural. The terms "include", "comprise", "have" and any variants thereof involved in this application are intended to cover non-exclusive inclusion; for example, a process, method, system, product or device including a series of steps or modules (units) is not limited to the listed steps or modules (units), but may include unlisted steps or modules (units), or may include other steps or modules (units) inherent in these processes, methods, products or devices. The terms "connected", "coupled" and the like involved in this application do not limit to physical or mechanical connections, but may include electrical connections, whether directly or indirectly. The "multiple" involved in this application refers to two or more. "And / or" describes the association relationship of associated objects, indicating that three relationships may exist. For example, "A and / or B" may represent: A exists alone, A and B exist simultaneously, and B exists alone. Usually, the character " / " indicates that the objects associated before and after are in an "or" relationship. The terms "first", "second", "third", etc. involved in this application are only used to distinguish similar objects and do not represent a specific sorting of the objects.

[0049] In this embodiment, an insulin infusion management device is provided. Figure 1 Schematic structural diagram of the insulin infusion management device of this embodiment; Figure 2 Schematic interface diagram of the insulin infusion management device of this embodiment; Figure 3 Schematic diagram of the information statistics display area of this embodiment. As Figure 1As shown in the figure, the insulin infusion management device includes a communication module 11 and a user interface 12. Among them, the communication module 11 is used to receive blood glucose monitoring information and insulin infusion information carrying time information; the user interface 12 includes a real-time monitoring interface; the real-time monitoring interface includes an information statistics display area 121; the horizontal axis of the set information statistics display area 121 is the time axis 1211, the first vertical axis 1213 is the insulin infusion dose reference value, and the second vertical axis 1214 is the blood glucose reference value; the time information is mapped on the time axis to form a first association relationship; the information statistics display area 121 displays a blood glucose change curve 1212 generated according to the blood glucose monitoring information and the first association relationship; the blood glucose change curve 1212 contains multiple blood glucose level recording points. Among them, when a blood glucose level recording point is selected by the first user input, the control information statistics display area 121 floats and displays a numerical display area 1218. The numerical display area 1218 is vertically connected to the selected blood glucose level recording point by a dotted line indicating line, so that the numerical display area 1218 and the blood glucose change curve 1212 are completely displayed simultaneously within the information statistics display area 121; the numerical display area 1218 is also used to receive the dragging operation input by the second user, dynamically select the blood glucose level recording point through the dragging operation, and the numerical display area 1218 is also used to associatedly display the corresponding blood glucose monitoring information and / or insulin infusion information according to the dynamically selected blood glucose level recording point.

[0050] Specifically, the above insulin infusion management device can specifically be any portable electronic device, such as a smart phone, a smart watch, and a handheld device, etc. Among them, the corresponding application program can be loaded and run in the electronic device to provide the above functions of receiving blood glucose monitoring information and insulin infusion information, and the function of displaying the corresponding user interface 12. The above communication module 11 can be a wireless communication module, such as a communication module implemented based on wireless communication technologies such as Bluetooth and Zigbee. In addition, the above communication module 11 can also be a wired communication module, such as it can be connected to the blood glucose monitoring device and the insulin infusion device based on USB. This embodiment does not make specific limitations on this.

[0051] Taking wireless communication as an example, the two parties participating in wireless communication are the insulin infusion management device and the blood glucose monitoring device, and / or the insulin infusion management device and the insulin infusion device. Each communication is initiated by the insulin infusion management device and a wireless connection is established. After the wireless connection is established, the insulin infusion management device can actively send a communication request to the insulin infusion device and the blood glucose monitoring device, and the insulin infusion device and the blood glucose monitoring device can respond to the communication request. During the communication process, data is sent and received in the form of communication messages between the insulin infusion management device, the insulin infusion device, and the blood glucose monitoring device.

[0052] More specifically, the insulin infusion management device communicates with an associated blood glucose monitoring device and insulin infusion management device through the communication module 11. After receiving the blood glucose monitoring information through the communication module 11, the received blood glucose monitoring information is plotted as a blood glucose change curve 1212 in the information statistics display area 121; in addition, after receiving the insulin infusion information through the communication module 11, the received insulin infusion information is plotted as a bar chart of the infusion information in the information statistics display area 121.

[0053] Based on this, the second vertical axis 1214 corresponding to the blood glucose change curve 1212 can be plotted on one side of the information statistics display area 121, for example, on the left side, to represent the blood glucose concentration, and the unit can be millimoles per liter (mmol / L). The range of this vertical axis can be set according to the actual application scenario, for example, from 0 mmol / L to 15 mmol / L. The vertical coordinates of the blood glucose change curve 1212 are evenly distributed from bottom to top. In particular, in some of the embodiments, the portions of the blood glucose change curve 1212 in different blood glucose value ranges can be represented by different colors. For example, when the blood glucose value is lower than the hypoglycemia standard value (e.g., 3.9 mmol / L), the curve segment of the corresponding blood glucose change curve is displayed in red; when the blood glucose value is higher than the hyperglycemia standard value (e.g., 10.0 mmol / L), the curve segment of the corresponding blood glucose change curve is displayed in yellow; and when the blood glucose value is within the blood glucose safety threshold range, the curve segment of the corresponding blood glucose change curve is displayed in green. The blood glucose change curve 1212 can be composed of a series of discrete points representing the blood glucose values at corresponding moments, for example, a curve connected by a series of discrete points. In addition, it can also be represented as a set of points distributed on the time axis composed of a series of discrete points. The blood glucose change curve 1212 is used to intuitively present the blood glucose level of the user in the past and current time periods.

[0054] In addition, through a first user input, for example, touching and holding or swiping the blood glucose level recording point in the information statistics display area 121 will cause the numerical display area 1218 to appear. When dragging the numerical display area 1218 to different blood glucose level recording points on the blood glucose change curve, the corresponding blood glucose monitoring information and / or insulin infusion information at that moment will be floatingly displayed in the numerical display area 1218 and disappear after being displayed for a certain period of time, for example, disappear after being displayed for 1 second, 2 seconds, or 5 seconds.

[0055] The first vertical axis 1213 can be plotted on the other side of the information statistics display area 121, for example, on the right side, to represent the infusion dose, and the first vertical axis 1213 can also be evenly distributed from top to bottom. The time range of the above time axis 1211 can be adjusted.

[0056] When a second user input for a drag operation on the numerical display area 1218 is received, the blood glucose level recording points are dynamically selected through the drag operation, and according to the dynamically selected blood glucose level recording points, blood glucose monitoring information and / or insulin infusion information are associated and displayed within the numerical display area 1218. It can be understood that in some embodiments, the blood glucose monitoring information, insulin infusion information, and time can be made to float and display together. In particular, based on Figure 2 As can be seen, in some embodiments, the basal rates set at different times can be different, so that a bar chart of basal rates with high and low changes is presented on the real-time monitoring interface.

[0057] Optionally, in response to a first user input, the numerical display area 1218 can be made to float and display within the information statistics display area 121, and the numerical display area 1218 is vertically connected to the selected blood glucose level recording point by a dotted line indicating line, so as to clearly indicate the association relationship between the specific numerical content presented within the numerical display area 1218 and the specific blood glucose level recording point on the blood glucose change curve, while avoiding the occlusion of the blood glucose change curve by the numerical display area 1218.

[0058] This embodiment can clearly and completely present the blood glucose change curve and the floating numerical information on the real-time monitoring interface at the same time, so as to facilitate the user to accurately and comprehensively know the blood glucose monitoring information and / or insulin infusion information corresponding to each moment, as well as the complete blood glucose change situation and insulin infusion change situation within a period of time.

[0059] In addition, after receiving the first user input, the insulin infusion management device will read the blood glucose level recording point selected by the first user input from multiple blood glucose level recording points, and obtain the blood glucose monitoring information and / or insulin infusion information corresponding to the time corresponding to the blood glucose level recording point recorded in advance. Then, the blood glucose monitoring information and / or insulin infusion information are filled into the numerical display area 1218 together. In addition, after reading the blood glucose monitoring information and insulin infusion information corresponding to the blood glucose level recording point, the read values can also be compared with the preset corresponding thresholds to determine whether the blood glucose monitoring information and insulin infusion information of the blood glucose level recording point are within the normal range. Then, a corresponding prompt of normal or abnormal value can also be given in the numerical display area 1218.

[0060] In this embodiment, by providing a floating display function in the information statistics display area 121, the blood glucose monitoring information and / or insulin infusion information of the recording points specified by the user are floatingly displayed in a way that does not block the blood glucose change curve based on the interaction with the user. It can present the blood glucose monitoring information and insulin infusion information corresponding to a single specific moment point that the user is concerned about, and the overall blood glucose change situation and insulin infusion change situation within a certain time range to the user at the same time, providing the user with a flexible and accurate way to recall the specific blood glucose monitoring information and insulin infusion information at each moment point. In addition, this embodiment can achieve sufficient interaction with the user, and present the blood glucose monitoring information and insulin infusion information concerned by the user based on the user input, thus realizing a more rich usage experience and improving the user experience of the infusion interface in insulin infusion management and blood glucose monitoring.

[0061] It should also be noted that this embodiment provides more user interaction methods. For example, dynamic dragging and pressing for floating display, combined with the interface graphic elements, can bring more operation experiences to the user. Compared with the interface display method that only uses graphics or text, the insulin infusion management device provided in this embodiment can meet the usage requirements of users in different scenarios.

[0062] The insulin management device provided in this embodiment obtains the patient's insulin infusion information and blood glucose monitoring information through wireless communication with the insulin infusion device and the continuous blood glucose monitoring device, and displays the insulin infusion information and blood glucose monitoring information on the user interface, ensuring the safety and reliability of insulin infusion control and blood glucose monitoring, and improving the user experience. Further, by integrating multi-dimensional blood glucose monitoring information, this embodiment mixes and displays the closed-loop blood glucose monitoring information and insulin infusion information in a time-corresponding manner in the same display area, which can provide the user with more comprehensive and sufficient blood glucose monitoring information, monitor the blood glucose change from multiple dimensions, improve the convenience of blood glucose monitoring and blood glucose control, and thus can simultaneously perform insulin infusion control, infusion display and blood glucose monitoring, thereby improving the user experience.

[0063] Among them, in one embodiment, the information statistics display area 121 is also used to display the blood glucose safety block 1219; the upper boundary of the blood glucose safety block 1219 corresponds to the upper limit value of the preset blood glucose safety threshold range; the lower boundary of the blood glucose safety block 1219 corresponds to the lower limit value of the preset blood glucose safety threshold range; the blood glucose safety block 1219 is used to monitor the change trend of the blood glucose change curve 1212. Among them, the part of the blood glucose change curve 1212 that exceeds the blood glucose safety block 1219 forms an alarm curve, and the display method of the alarm curve is different from that of the blood glucose change curve 1212.

[0064] Specifically, the blood glucose safety block 1219 can be displayed below the blood glucose change curve 1212 in the form of a background graph, and the blood glucose change curve 1212 can be superimposed above the blood glucose safety block 1219. The blood glucose safety threshold range can be the threshold range under normal blood glucose conditions set based on medical standards.

[0065] The alarm curve can be displayed in a color different from that of the blood glucose change curve 1212 within the blood glucose safety threshold range. Exemplarily, when the blood glucose change curve is lower than the lower limit value of the blood glucose safety threshold range (e.g., 3.9 mmol / L), the curve segment of the corresponding blood glucose change curve can be displayed in red to form an alarm curve; when the blood glucose value is higher than the upper limit value of the blood glucose safety threshold range (e.g., 10.0 mmol / L), the curve segment of the corresponding blood glucose change curve is displayed in yellow to form an alarm curve. When the blood glucose value is within the blood glucose safety threshold range, the curve segment of the corresponding blood glucose change curve is displayed in green.

[0066] In this embodiment, by displaying the blood glucose safety block 1219 in the information statistics display area 121, it can be more clearly shown whether the change in blood glucose value exceeds the blood glucose safety threshold range through comparison with the blood glucose change curve 1212 in terms of data presentation, thus facilitating the user to more timely and clearly understand their own blood glucose status.

[0067] In one embodiment, the user interface 12 further includes a large dose infusion setting interface, which is used to set single large dose infusion information or multiple large dose infusion information at the same moment in response to a third user input; the information statistics display area 121 is further used to display a first bar graph 1220, and the first bar graph 1220 includes a first single-color block and a first multi-color combination block. The first single-color block is used to represent single large dose numerical information; the first multi-color combination block is used to represent multiple large dose infusion information at the same moment.

[0068] Among them, the large dose infusion information can be displayed in the form of a bar graph on the information statistics display area 121. The vertical axis on one side of the information statistics display area 121 represents the infusion dose of the large dose, and the insulin infusion information over a period of time is displayed in a graph form. It can be understood that the first bar graph 1220 will change as the insulin infusion information is updated, and present the change situation of the large dose infusion information in the past and at the current time to the user.

[0069] Exemplarily, if the user, at a certain moment, such as 18:00, controls the insulin infusion device to continuously perform multiple large-dose infusion control settings through the above insulin infusion management device. For example, the first set infusion dose is 8.4U (insulin dose unit), the second set infusion dose is 2.4U, and the third set infusion dose is 2.4U. Then the insulin infusion management device will separately count the multiple infusions at this moment, and the first combined block corresponding to the multiple consecutive infusions at the same moment will be displayed on the information statistics display area 121. For details, please refer to Figure 3 the first multi-color combined block in it. Among them, the upper column, middle column, and lower column of the first multi-color combined block are distinguished and displayed by different colors or different textures, and a text description of the dose of multiple consecutive infusions is correspondingly displayed above the graph. When the user performs a single large-dose insulin infusion setting at a certain moment, it is displayed as a first single-color block on the information statistics display area 121. For example Figure 2 the first single-color block in it.

[0070] In this embodiment, by displaying the multiple large-dose insulin infusions set at the same moment in a combined form in the first bar chart and displaying the single large-dose infusion information as a single-color block, it is possible to record the single-set large dose and the multiple-set large-dose infusions, and clearly, concisely, accurately, and intuitively present the infusion information in the continuous large-dose infusion scenario, facilitating the user to more clearly and comprehensively manage the large-dose infusion information and enhancing the user experience.

[0071] In addition, in one embodiment, the user interface 12 further includes a basal rate infusion setting interface, which is used to respond to the fourth user input to set the regular basal rate infusion information or the temporary basal rate infusion information at different times; the information statistics display area 121 also displays a second bar chart 1222, which is used to display the regular basal rate information or the temporary basal rate numerical information at different times; among them, there is a partial overlapping area between the first bar chart 1220 and the second bar chart 1222, and the first bar chart 1220 and the second bar chart 1222 are distinguished and displayed.

[0072] Among them, as Figure 2 shown, the columns in the first bar chart 1220 can be long columns. The second bar chart and the first bar chart 1220 can be distinguished and displayed by different colors or textures. The second bar chart 1222 can also be calibrated for the dose based on the first vertical axis 1213. In this embodiment, by distinguishing and displaying the two different infusion types of large-dose infusion and basal rate infusion through different bar charts, it is possible to present more sufficient and comprehensive infusion information in the same display area, providing convenience for the user to manage different types of insulin infusions.

[0073] In particular, in one embodiment, the user interface 12 further includes an event recording interface; the event recording interface is used to record the event time and event behavior corresponding to blood glucose monitoring management in response to a fifth user input; the information statistics display area 121 is further used to display an event identifier 1221. For details, please refer to Figure 3 , and arrange the event identifiers 1221 corresponding to the timeline 1211.

[0074] In some of these embodiments, the event time and event behavior can be recorded by clicking the record button on the event recording interface, and the event recording interface will display each event according to the date. After the user selects a recorded event on the event recording interface, clicking the delete button can delete the corresponding event. Clicking the date button can select the corresponding event recording date. Exemplarily, the user can record events such as injection events (e.g., "14:53 inject 1U of premixed insulin"), medication events (e.g., "14:02 take cold medicine aspirin"), snack events (e.g., "13:40 snack 50.0g"), postprandial blood glucose change events (e.g., "13:40 10.0 mmol / L after lunch"), exercise events (e.g., "11:38 indoor running for 3 hours"), etc. The graphic content and background color in the event identifiers of different events are different.

[0075] That is, when the user has a meal, including breakfast, lunch, dinner and snacks, exercises or other events, the corresponding events can be recorded through the event recording interface. As Figure 3 shown, the information statistics display area 121 will arrange and display the corresponding event identifiers 1221 at the corresponding moments on the timeline 1211, and different patterns can be presented inside the event identifier 1221 according to the specific event type. The user can intuitively understand the events such as meals and exercises that occurred during the specified time period based on each event identifier 1221 on the information statistics display area 121. It should also be noted that since the insulin infusion device is continuously infusing insulin, the infusion information on the information statistics display area 121 will be continuously updated, and the event identifier 1221 will also move as the time on the timeline 1211 is updated. When the time of the event exceeds the time period displayed on the timeline 1211, the event identifier will disappear.

[0076] When there are multiple event identifiers, different event identifiers will be arranged above the corresponding moments on the timeline 1211 based on the corresponding event identifier information. In particular, when multiple events occur at the same moment, multiple event identifiers can be arranged from bottom to top according to the input order at the same moment.

[0077] In this embodiment, by providing an interface for recording events related to blood glucose monitoring management for the user and displaying the relevant event identifiers input by the user, information related to blood glucose can be presented in a more multi-dimensional manner. Additionally, by arranging and displaying the event identifiers based on time information, the correlation between the events corresponding to blood glucose monitoring management and the changes in blood glucose levels can be presented to the user more accurately.

[0078] Additionally, in one embodiment, the information statistics display area 121 displays at least one time label 1225; the time label 1225 corresponds to a time segment on the time axis 1211; the information statistics display area 121 is further configured to respond to a first user input to select the time label 1225, and display the time segment on the corresponding time axis 1211 according to the switching of the selected time label 1225, as well as the blood glucose change curve 1212 and the event identifier 1221 within the corresponding displayed time segment.

[0079] By setting different time labels 1225, a variety of time display range options can be provided for the user, facilitating the user to view the blood glucose changes, events related to blood glucose monitoring management, and insulin infusion conditions within different time spans based on their own needs, further enhancing the user experience.

[0080] In one embodiment, the real-time monitoring interface further includes a blood glucose real-time display area 1226; the blood glucose real-time display area 1226 is configured to display the currently real-time monitored blood glucose monitoring information, and generate a blood glucose abnormality prompt when the currently monitored blood glucose information exceeds the blood glucose safety threshold range.

[0081] Among them, the blood glucose real-time display area 1226 can display the currently latest read blood glucose monitoring information, and display the blood glucose values in different blood glucose states in different colors. At the same time, the change trend of blood glucose can also be indicated by arrows of different colors, different numerical values, and different directions. Both the blood glucose value and the blood glucose trend indication arrow are set within the blood glucose real-time display area 1226, and the user can intuitively understand the current blood glucose monitoring information status and the blood glucose change trend at the same time. For example Figure 2 when there is no upward or downward trend in the user's blood glucose, an arrow pointing horizontally to the right can be displayed beside the reading; when the user's blood glucose increases, an upward arrow can be displayed beside the reading. When the user's blood glucose decreases, a downward arrow will be displayed beside the reading in the blood glucose real-time display area 1226. If the current blood glucose value has fallen below the lower limit of the blood glucose safety threshold range, the color of the reading will be changed, for example, the reading will be displayed in red, thus forming a blood glucose abnormality prompt. It can also be understood that the blood glucose abnormality prompt can also be generated in other forms, such as directly outputting the text of blood glucose abnormality, or an image representing blood glucose abnormality, or flashing, etc.

[0082] Based on this, the user can simultaneously understand the current blood glucose status and its changing trend through the real-time blood glucose display area, and can also timely learn about the abnormal blood glucose status and take corresponding measures to change the status of the insulin infusion device.

[0083] In some of these embodiments, the real-time monitoring interface further includes an insulin infusion display area 1227; the insulin infusion display area 1227 is used to display basal rate infusion information and bolus infusion information; the bolus infusion information includes the dose value and infusion time of the most recent bolus infusion.

[0084] Specifically, the insulin infusion display area 1227 displays basal rate numerical information, such as displaying basal rate B1 "0.900 U / h", displaying the dose value of the last bolus infusion such as "6.0 U", and the last bolus infusion time "08-26 12:30", etc.

[0085] In this embodiment, by displaying the current insulin infusion status on the real-time monitoring interface, it is convenient for the user to clearly understand the current insulin infusion type and infusion situation.

[0086] Additionally, in some of these embodiments, the real-time monitoring interface further includes a device information display area 1228; the device information display area 1228 is used to display the remaining usage time of the associated blood glucose monitoring device.

[0087] Exemplarily, the blood glucose monitoring device can be a continuous glucose monitoring sensor (Continuous Glucose Monitoring, abbreviated as CGM). By communicating with the CGM sensor, the remaining usage time of the CGM sensor can be obtained and displayed, such as prompting "11.1 days remaining available". Among them, a timer is set inside the CGM sensor, and this timer is usually associated with the working life of the CGM sensor and can display the remaining usage time on the supporting software or device.

[0088] In this embodiment, by displaying the remaining usage time of the blood glucose monitoring device, it can provide the user with a clear and accurate device usage status, facilitating the user to timely maintain the blood glucose monitoring device.

[0089] In particular, in some embodiments, the device information display area 1228 can also prompt the unavailable state of the device. When the blood glucose monitoring device is disconnected from the insulin infusion management device, or when the blood glucose monitoring device malfunctions, etc., in the device information display area 1228 of the user interface, a text description of "Currently not connected to CGM" is used for prompting, and in the real-time blood glucose display area 1226, a short dash "--" or other forms are used to prompt that the current blood glucose monitoring information has not been read. It can be understood that the insulin infusion management device can also form prompts in other graphical or textual forms, and this embodiment does not make specific limitations on this.

[0090] In addition, in some embodiments, the real-time monitoring interface further includes an active insulin display area 1229, and the active insulin display area 1229 is used to indicate the infusion dose of the insulin that is currently taking effect.

[0091] In addition, in some embodiments, the real-time monitoring interface further includes a first details button 1230. After the user clicks the first details button 1230, a first prompt box including the status information of the associated blood glucose monitoring device, the status information of the insulin infusion device, and the total amount of insulin and the average blood glucose within a certain time period will pop up on the real-time monitoring interface. Alternatively, when the user clicks the first details button 1230 in the upper right corner of the real-time monitoring interface, a first prompt box will pop up above the real-time monitoring interface, which includes information such as the CGM brand name, serial number, connection status, remaining days, activation time, time since last calibration, etc. Thus, the user can quickly learn about the blood glucose situation, insulin infusion situation, and the status of the associated devices within the preset time period through this first prompt box.

[0092] In particular, in one embodiment, the real-time monitoring interface further includes a control mode display area 1232, and the control mode display area 1232 is used to indicate whether the current control of the insulin infusion device is in manual mode or automatic mode. When the control mode display area 1232 shows manual mode, the infusion control of the insulin infusion device is manually controlled by the user. When the control mode display area 1232 shows automatic mode, the infusion control of the insulin infusion device is automatically controlled based on the insulin infusion management device.

[0093] In addition, the real-time monitoring interface further includes a communication icon 1233 for indicating the communication connection with the blood glucose monitoring device. Additionally, the real-time monitoring interface can also include alarm icons for displaying alarms with different priorities.

[0094] In some embodiments, such as Figure 3As shown, the above real-time monitoring interface can also set a second details button 1235 in the information statistics display area 121. After the user clicks the second details button 1235, a second prompt box will pop up above the real-time monitoring interface, which includes: remaining drug amount, remaining battery power, duration of pump connection, connection status of CGM, target blood glucose value, total insulin amount today, total insulin amount yesterday, average blood glucose today, average blood glucose yesterday, and other information. Thus, the user can quickly learn about the blood glucose situation, insulin infusion situation, and associated device status within a preset time period through this second prompt box. In addition, the real-time monitoring interface can also set a magnification button 1236. The user clicks the magnification button 1236 to magnify and view the information statistics display area 121, obtaining a magnified view of the horizontal display area, which is convenient for the user to view the information in the information statistics display area more clearly.

[0095] Figure 4 is a schematic structural diagram of the large-dose estimation interface of this embodiment. In one embodiment, the user interface 12 further includes a large-dose estimation interface as Figure 4 shown; the large-dose estimation interface includes a blood glucose value setting area 131; the blood glucose value setting area 131 is used to display a first option 1311 and a second option 1312; the first option 1311 is used to select the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information; the second option 1312 is used to select the current finger-prick blood value as the current blood glucose monitoring information; the blood glucose value setting area 131 is further used to, in response to the sixth user input for selecting the first option 1311, set the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information, and set the second option 1312 to not respond to user input operations; and, in response to the seventh user input for selecting the second option 1312, set the received current finger-prick blood value as the current blood glucose monitoring information. It can be understood that the large-dose estimation interface can include more areas, which are not limited herein.

[0096] After the user selects the first option 1311, the second option 1312 will be grayed out, and at this time, the current blood glucose value will be set according to the dynamic continuous blood glucose monitoring value. When the user selects the second option 1312, the finger-prick blood value with higher blood glucose monitoring accuracy can be used as the current blood glucose value. Among them, the current finger-prick blood value can be either transmitted by the finger-prick blood collection device or input by the user according to the finger-prick blood test result. In this embodiment, two ways to determine the current blood glucose value are provided for the user, which can facilitate the user to select more convenient and accurate blood glucose data as the current blood glucose value according to the actual situation, thereby improving the flexibility of obtaining the current blood glucose value and enhancing the user experience.

[0097] In one embodiment, the user interface 12 further includes a statistical analysis interface; the statistical analysis interface includes a blood glucose statistics area, a blood glucose overview area, and an injection overview area; the blood glucose statistics area is configured to respond to the user's selection of a statistical date, and statistically display a blood glucose change statistical chart, a bolus infusion statistical chart, and a basal rate infusion statistical chart corresponding to the selected statistical date; the blood glucose overview area is configured to respond to the user's selection of a statistical date, and statistically display multi-dimensional blood glucose status quantification indicators corresponding to the selected statistical date; the injection overview area is configured to respond to the user's selection of a statistical date, and statistically display the total amount of insulin, the total amount of bolus, the total amount of basal rate, and the total amount of carbohydrates corresponding to the selected statistical date.

[0098] In the statistical analysis interface provided in this embodiment, based on the user's selection of a statistical date, it can output blood glucose statistical information corresponding to the selected date to the user, including a blood glucose overview area with time in range (TIR), time below range (TBR), time above range (TAR), and mean glucose (MG), as well as statistical information including the total amount of insulin, the total amount of bolus, the total amount of basal rate, and the total amount of carbohydrates. In particular, in one embodiment, the statistical analysis interface is further configured to generate a dynamic glucose profile in response to the input of the twelfth user.

[0099] In particular, in some embodiments, the statistical analysis interface may include statistical analysis for changes in algorithm parameters and mode switching. The statistical analysis interface includes a tab bar, a statistical information display area, a statistical date button, and an information sending button. Among them, the user can switch to the "temporary basal", "mode switching", "care", "algorithm parameters", and "all" tabs through the tab bar to view corresponding statistical information. For example, under the "temporary basal" tab, statistical information related to the setting and change of the temporary basal rate can be displayed; under the "mode switching" tab, switching information for switching the insulin infusion device to the above-mentioned "manual mode" or "automatic mode" can be displayed; under the "care" tab, information on injection and reset of the insulin infusion device can be displayed; under the "algorithm parameters" tab, information related to changes in algorithm parameters can be displayed; under the "all" tab, statistical information corresponding to the above-mentioned "temporary basal", "mode switching", "care", and "algorithm parameters" tabs is displayed.

[0100] The statistical information display area can display corresponding statistical information by date; the statistical date button can be used to switch to display statistical information corresponding to different dates; when the user clicks the information sending button, the statistical information can be sent, for example, sent to other mobile terminals associated with the user.

[0101] In this embodiment, by statistically analyzing information such as blood glucose change information, insulin infusion information, and associated device status, etc., it is convenient for users to understand the overview information of insulin infusion control, thereby improving the efficiency of users in controlling insulin infusion.

[0102] Optionally, in one embodiment, the user can customize the display of each area module in the real-time monitoring interface. The real-time monitoring interface can be divided into several operable area modules, and a listening event is associated with each area module. When it is detected that the user long-presses a certain area module, the setting of hiding or displaying the area module is performed, and the position layout of different area modules is modified.

[0103] Optionally, in one embodiment, users of different insulin value management devices can follow each other. The user follow list interface includes an operation bar, a tab bar, and a follow list area. Among them, the user can add new followers by clicking the add button in the operation bar, display the follow prompt of the follow list by clicking the prompt button in the operation bar, and display the corresponding follower messages by clicking the message button. The user selects the "All", "Followed by Me", and "Followed by Others" tabs in the tab bar, and different user lists are correspondingly displayed in the follow list area. The follow list area can display the user name, user contact information, and the blood glucose health status and ranking of the user.

[0104] After becoming a follower of a certain user, the user can click on the detail page of the followed user from their own follow list interface to view the corresponding diagnosis and treatment information. By setting the user follow list interface in this embodiment, it is convenient for medical staff or family members to remotely monitor the patient. All followed users are displayed in the follower list. They are automatically ranked from top to bottom according to the level of the treatment effect TIR. In addition, like operations and private message sending operations can also be performed for other users.

[0105] In this embodiment, an insulin infusion management system is provided. Figure 5 It is a schematic structural diagram of the insulin infusion management system of this embodiment. As Figure 5 shown, the insulin infusion management system includes: a blood glucose monitoring device 52, an insulin infusion device 54, and the insulin infusion management device 56 provided in any of the above embodiments; wherein: the blood glucose monitoring device 52 is used to perform blood glucose monitoring to obtain blood glucose monitoring information; the insulin infusion management device 56 is used to receive and display blood glucose monitoring information and insulin infusion information, and generate an infusion instruction according to the blood glucose monitoring information and insulin infusion information; the insulin infusion device 54 is used to receive the infusion instruction to perform insulin infusion.

[0106] Among them, the insulin infusion management device 56 is communicatively connected to the blood glucose monitoring device 52 and the insulin infusion device 54 respectively. The blood glucose monitoring device 52 can be a CGM. The insulin infusion device can be an insulin pump. The blood glucose monitoring device 52 and the insulin infusion device 54 can be integrally provided or separately provided, and this embodiment does not make specific limitations thereon.

[0107] Figure 6 FIG. is a schematic structural diagram of an insulin infusion device 54 according to this embodiment, as Figure 6 shown, the insulin infusion device 54 includes: a battery compartment 541, a reservoir adapter 542, a reservoir chamber 543, and a touch screen 544. During use, the insertion mechanism of the insulin infusion device 54 is inserted under the human skin, and the other parts of the insulin infusion device 54 are attached to the surface of the human skin. The insulin infusion management device 56 controls the insulin infusion device 54 to perform insulin infusion on the human body based on the communication with the insulin infusion device 54.

[0108] Exemplarily, in some of these embodiments, the communication between the insulin infusion management device 56 and the insulin infusion device 54 may include the following device binding and pairing process: after the insulin infusion management device 56 sends an initiation request for pairing or de - pairing to the insulin infusion device 54, the insulin infusion device 54 sends an initiation response for pairing or de - pairing to the insulin infusion management device 56, and the initiation response contains a binding feature code randomly generated in the current state and not all zero; when the insulin infusion management device 56 and the insulin infusion device 54 perform pairing or de - pairing confirmation, the insulin infusion device 54 first receives the pairing or de - pairing confirmation request sent by the insulin infusion management device 56, and then determines whether the binding feature code in the confirmation request is the binding feature code contained in the initiation response. If so, the pairing or de - pairing operation is confirmed to be successful, otherwise the pairing or de - pairing operation is confirmed to be failed.

[0109] The above - mentioned insulin infusion management system can provide users with more comprehensive and sufficient blood glucose monitoring information, monitor blood glucose changes from multiple dimensions, improve the convenience of blood glucose monitoring and display for blood glucose control, and thus can simultaneously perform insulin infusion control, infusion display, and blood glucose monitoring, thereby enhancing the user experience.

[0110] In this embodiment, an insulin infusion control method is also provided for the insulin infusion management device provided in the above - mentioned embodiment; Figure 7 FIG. is a flowchart of the insulin infusion management method according to this embodiment, as Figure 7 shown, the insulin infusion management method includes the following steps:

[0111] Step S701, receiving blood glucose monitoring information and insulin infusion information carrying time information;

[0112] Step S702: Display a real-time monitoring interface, where the real-time monitoring interface includes an information statistics display area;

[0113] Step S703: Set the horizontal axis of the information statistics display area as the time axis, the first vertical axis as the insulin infusion dose reference value, and the second vertical axis as the blood glucose reference value; The time information is mapped onto the time axis to form a first association relationship;

[0114] Step S704: Control the information statistics display area to display a blood glucose change curve generated based on the blood glucose monitoring information and the first association relationship; The blood glucose change curve includes multiple blood glucose level recording points. Among them, when a blood glucose level recording point is selected by the first user input, control the information statistics display area to floatingly display a numerical display area, and the numerical display area is vertically connected to the selected blood glucose level recording point through a dotted line indication line, so that the numerical display area and the blood glucose change curve are fully displayed simultaneously within the information statistics display area;

[0115] Step S705: Receive a dragging operation input by the second user, dynamically select a blood glucose level recording point through the dragging operation, and the numerical display area is further used to associatively display corresponding blood glucose monitoring information and / or insulin infusion information according to the dynamically selected blood glucose level recording point.

[0116] For the above steps S701 to S705, through wireless communication with the insulin infusion device and the continuous blood glucose monitoring device, obtain the patient's insulin infusion information and blood glucose monitoring information, display the insulin infusion information and blood glucose monitoring information on the user interface, ensure the safety and reliability of insulin infusion control and blood glucose monitoring, and improve the user experience. Further, in this embodiment, by integrating multi-dimensional blood glucose monitoring information and displaying the closed-loop blood glucose monitoring information and insulin infusion information in a time-corresponding manner in the same display area, it can provide users with more comprehensive and sufficient blood glucose monitoring information, monitor blood glucose changes from multiple dimensions, improve the convenience of blood glucose monitoring and blood glucose control, so as to simultaneously perform insulin infusion control, infusion display, and blood glucose monitoring, thereby improving the user experience.

[0117] It can be understood that in the specific examples of the insulin infusion management method in this embodiment, the examples described in the above embodiments and optional implementation manners of the insulin infusion management device can also be referred to, and will not be elaborated in this embodiment.

[0118] It should be understood that the specific embodiments described here are only used to explain this application, rather than to limit it. According to the embodiments provided in this application, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of this application.

[0119] It should be noted that the user information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data for analysis, stored data, displayed data, etc.) involved in this application are all information and data that have been authorized by the user or fully authorized by all parties.

[0120] Obviously, the accompanying drawings are only some examples or embodiments of this application. For those of ordinary skill in the art, this application can also be applied to other similar situations based on these drawings without creative efforts. Additionally, it can be understood that although the work done during this development process may be complex and time-consuming, for those of ordinary skill in the art, certain design, manufacturing, or production changes based on the technical content disclosed in this application are only conventional technical means and should not be regarded as insufficient disclosure of this application.

[0121] The term "embodiment" in this application means that the specific features, structures, or characteristics described in connection with the embodiments can be included in at least one embodiment of this application. The phrase appears in various positions in the specification and does not necessarily mean the same embodiment, nor does it mean being independent or alternative to other embodiments and mutually exclusive. Those of ordinary skill in the art can clearly or implicitly understand that the embodiments described in this application can be combined with other embodiments without conflict.

[0122] The above-described embodiments only represent several implementation manners of this application, and their descriptions are relatively specific and detailed, but should not be construed as limiting the scope of patent protection. It should be noted that for those of ordinary skill in the art, without departing from the concept of this application, several modifications and improvements can still be made, and these all fall within the protection scope of this application. Therefore, the protection scope of this application shall be subject to the appended claims.

Claims

1. An insulin infusion management device, characterized in that: include: A communication module (11) and a user interface (12); wherein: the communication module (11) is used to receive blood sugar monitoring information and insulin infusion information carrying time information; The user interface (12) includes a large dose infusion setting interface and an information statistics display area (121); The bolus infusion setting interface is used to set single bolus infusion information or multiple bolus infusion information at the same time in response to a third user input; The information statistics display area (121) is used to display a first bar graph (1220), and the first bar graph (1220) is used to display to the user the changes in the large-dose infusion information in the past and the current time; wherein the first bar graph (1220) includes a first monochrome block and / or a first multi-color combination block, and the first monochrome block is used to display a single large-dose infusion information, and the first multi-color combination block is used to display multiple large-dose infusion information at the same time.

2. The insulin infusion management device according to claim 1, characterized in that: The upper column, the middle column and the lower column of the first multi-color combination block are distinguished and displayed by different colors or different textures; The information statistics display area (121) is also used to display text descriptions of dosages of multiple consecutive infusions above the first multi-color combination block.

3. The insulin infusion management device according to claim 1, characterized in that: The user interface (12) further comprises a bolus estimation interface; the bolus estimation interface comprises a blood glucose value setting area (131); the blood glucose value setting area (131) is used to display a first option (1311) and a second option (1312); the first option (1311) is used to select a dynamic continuous blood glucose monitoring value as current blood glucose monitoring information; the second option (1312) is used to select a current finger blood value as current blood glucose monitoring information; The blood glucose value setting area (131) is also used to respond to a selection operation of the first option (1311) input by a sixth user, use the dynamic continuous blood glucose monitoring value as current blood glucose monitoring information, and set the second option (1312) to not respond to user input operations; And, in response to the seventh user inputting a selection operation on the second option (1312), the received current finger blood value is used as the current blood sugar monitoring information.

4. The insulin infusion management device according to claim 3, characterized in that: The user interface (12) further comprises a basal rate infusion setting interface, wherein the basal rate infusion setting interface is used to set regular basal rate infusion information or temporary basal rate infusion information at different times in response to a fourth user input; The information statistics display area (121) also includes a second bar graph (1222), which is used to display regular basic rate information or temporary basic rate numerical information at different times; wherein, there is a partial overlapping area between the first bar graph (1220) and the second bar graph (1222), and the first bar graph (1220) and the second bar graph (1222) are displayed separately.

5. The insulin infusion management device according to claim 4, characterized in that: The user interface (12) further comprises a statistical analysis interface; the statistical analysis interface comprises a blood sugar statistics area, a blood sugar overview area and an injection overview area; The blood sugar statistics area is used to count and display the blood sugar change statistics chart, the large dose infusion statistics chart and the basal rate infusion statistics chart corresponding to the statistics date in response to the user's selection operation of the statistics date; The blood sugar overview area is used to count and display the multi-dimensional blood sugar status quantitative indicators of the corresponding statistical date in response to the user's selection operation of the statistical date; The injection overview area is used to count and display the total amount of insulin, the total amount of large doses, the total amount of basal rate and the total amount of carbohydrates on the corresponding statistical date in response to the user's selection operation on the statistical date.

6. The insulin infusion management device according to any one of claims 1 to 5, characterized in that: The user interface (12) also includes a real-time monitoring interface; The real-time monitoring interface also includes a control mode display area (1232); the control mode display area (1232) is used to indicate whether the current control of the insulin infusion device is a manual mode or an automatic mode; wherein, when the control mode display area (1232) displays the manual mode, the infusion control of the insulin infusion device is manually controlled by the user; when the control mode display area (1232) displays the automatic mode, the infusion control of the insulin infusion device is automatically based on the control of the insulin infusion management device.

7. The insulin infusion management device according to claim 6, characterized in that: The real-time monitoring interface also includes a first details button (1230); The first details button (1230) is used to pop up a first prompt box on the real-time monitoring interface in response to a user click operation; wherein: the first prompt box contains status information of the associated blood glucose monitoring device, status information of the insulin infusion device, and a first prompt box of the total amount of insulin and average blood glucose within a preset time period; or, The first prompt box pops up above the real-time monitoring interface; the first prompt box contains: the brand name, serial number, connection status, remaining days, activation time, and time since the last calibration of the associated blood glucose monitoring device.

8. The insulin infusion management device according to claim 6, characterized in that: The real-time monitoring interface also includes an insulin infusion display area (1227) and a device information display area (1228); The insulin infusion display area (1227) is used to display basal rate infusion information and bolus infusion information; the bolus infusion information includes the dose value and infusion time of the most recent bolus infusion; The device information display area (1228) is used to display the remaining usage time of the associated blood glucose monitoring device.

9. The insulin infusion management device according to claim 6, characterized in that: The real-time monitoring interface is divided into a plurality of operable area modules; each of the area modules is associated with a monitoring event; In response to a user's customized display operation on any area module, the area module operated by the user is hidden, displayed, or the position layout is modified.

10. An insulin infusion management system, characterized in that: include: A blood glucose monitoring device (52), an insulin infusion device (54), and an insulin infusion management device (56) according to any one of claims 1 to 8; wherein: The blood sugar monitoring device (52) is used to perform blood sugar monitoring to obtain blood sugar monitoring information; The insulin infusion management device (56) is used to receive and display the blood sugar monitoring information and the insulin infusion information, and generate an infusion instruction according to the blood sugar monitoring information and the insulin infusion information; The insulin infusion device (54) is used to receive the infusion instruction and perform insulin infusion.

11. The insulin infusion management system according to claim 10, characterized in that: The insulin infusion management device (56) is further used to send an initiation request for pairing or unpairing to the insulin infusion device (54); The insulin infusion device (54) is further used to send an initiation response for pairing or unpairing to the insulin infusion management device (56) in response to the initiation request; wherein the initiation response includes a binding feature code; The insulin infusion device (54) is used to receive a pairing or unpairing confirmation request sent by the insulin infusion management device (56) when confirming pairing or unpairing with the insulin infusion management device (56), and determine whether the binding feature code in the confirmation request is the binding feature code included in the initiation response; if so, confirm that the pairing or unpairing operation is successful; otherwise, confirm that the pairing or unpairing operation fails.

Images